The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A. Results of a double-blind, placebo-controlled, multicenter study. - Clark,W.M.; Albers,G.W.; Madden,K.P.; Hamilton,S. (Stroke, 2000)